Subcutaneous tumor growth was clearly decreased by silencing CRIP1 and increased with CRIP1 overexpression in tumor cells, further supporting the argument that CRIP1 acts as an oncogene in GC (Fig. 1K, L). This evidence concerns the gene CRIP1 and gastric cancer.